Tech Company Financing Transactions

VLST Funding Round

On 6/16/2006, VLST received $55 million in Series B funding from TPG Capital, Amgen Ventures and Arch Venture Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

307 Westlake Ave. North 300
Seattle, WA 98109
USA

Phone

(206) 262-5500

Website

www.vlstcorp.com

Email Address

[email protected]

Overview

VLST Corporation is a privately held biotechnology company that has developed a novel and streamlined approach to speed the development of effective therapeutics for the treatment of inflammatory and autoimmune diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Martin Simonetti

        

Chief Scientific Officer

Teresa Foy

        

VP - Bus. Development

Ron Myers

        

VP - Finance

Brian Blackman

        

Browse more venture capital transactions:

Prev: 6/15/2006: ContentNext Media venture capital transaction
Next: 6/16/2006: Spiceworks venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary